Protein Information

ID 541
Name acetylcholine receptors (protein family or complex)
Synonyms Acetylcholine receptor; Acetylcholine receptors

Compound Information

ID 1328
Name nicotine
CAS

Reference

PubMed Abstract RScore(About this table)
19477134 Zheng F, McConnell MJ, Zhan CG, Dwoskin LP, Crooks PA: QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum. Eur Neuropsychopharmacol. 2009 Aug;19(8):551-61. Epub 2009 Mar 10.
Maximal inhibition (I (max)) of the agonist effect is an important pharmacological property of inhibitors that interact with multiple receptor subtypes that are activated by the same agonist and which elicit the same functional response. This report represents the first QSAR study on a set of 66 mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating nicotine-evoked dopamine release, conducted using multi-linear regression (MLR) and neural network (NN) analysis with the maximal inhibition (I (max)) values of the antagonists as target values. The statistical results for the generated MLR model were: r (2)=0.89, rmsd=9.01, q (2)=0.83 and loormsd=11.1; the statistical results for the generated NN model were: r (2)=0.89, rmsd=8.98, q (2)=0.83 and loormsd=11.2. The maximal inhibition values of the compounds exhibited a good correlation with the predictions made by the QSAR models developed, which provide a basis for rationalizing selection of compounds for synthesis in the discovery of effective and selective second generation inhibitors of nAChRs mediating nicotine-evoked dopamine release.
31(0,1,1,1)